Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Neuropharmacology. 2016 Mar 3;107:40–48. doi: 10.1016/j.neuropharm.2016.02.036

Fig. 2.

Fig. 2

1-NA-PP1 pharmacokinetics after intraperitoneal injection of 30mg/kg 1-NA-PP1. Data shown are (A) plasma and (B) brain concentrations of 1-NA-PP1, with n = 3 for each data point.